Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2013

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole

Patients allocated to aripiprazole will be prescribed daily oral dose of drug, based on individual response and side-effects. Suggested starting dose will be 10 mg/day and dose range will be 10-30 mg/day.

DRUG

Olanzapine

Patients allocated to olanzapine will be prescribed daily oral dose of drug, based on individual patients' response and side-effect burden. Suggested starting dose will be 5 mg/day and dose range will be 10-20 mg/day.

DRUG

Haloperidol

"Patients allocated to haloperidol FGA arm will be prescribed daily oral dose of drug, based on individual patients' response and side-effect burden.~Suggested starting dose will be 1-3 mg/day and dose range 3-10 mg/day (chlorpromazine equivalents: suggested starting dose 50-100 mg/day; dose range 150-300 mg/day)."

Trial Locations (1)

16125

Department of Mental Health, Genoa

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Mario Negri Institute for Pharmacological Research

OTHER